Accepted Abstracts

Abstract Submission Guidelines

1. Purpose of the Guide

This guide explains the requirements for submitting abstracts for oral and poster presentations at a medical conference. It is intended to help authors prepare clear, ethical, scientifically meaningful, and well-structured submissions.

2. Who May Submit

Active physicians, researchers, healthcare professionals, educators, and public health specialists from Armenia.
Armenian healthcare professionals and researchers working abroad.
International collaborators conducting work in partnership with Armenian professionals or institutions.
Individuals or teams whose work contributes to healthcare, medical education, biomedical research, public health, or health system development in Armenia.

3. Why Submit

Present scientific, clinical, educational, or public health work to an international professional audience.
Share research findings, clinical experience, and innovative healthcare initiatives.
Promote collaboration between professionals in Armenia and the Armenian medical diaspora.
Increase the visibility of work contributing to health and healthcare-system improvement.

4. Young Investigator Award Session

Applicants under 40 years of age may be eligible for the Young Investigator Award Session (YIA).

The first author must be under 40 years old at the time of submission.
The first author should be the main contributor to the submitted work.
The presenting author should preferably be the first author.
Eligible abstracts may be evaluated based on scientific quality, innovation, methodology, relevance, potential impact, and presentation quality.

5. Accepted Abstract Types

Original research studies.
Clinical research.
Basic or translational biomedical research.
Public health and health-system studies.
Medical education projects.
Quality improvement or healthcare innovation projects.
Clinical case reports or case series.

Strict Quality Note

Original research studies will generally be prioritized. Clinical cases should be submitted only if they present a rare condition, diagnostic challenge, therapeutic lesson, important complication, or clear educational value.

Purely descriptive, incomplete, or “results will be discussed” abstracts should be avoided unless explicitly permitted by the conference rules.

6. General Abstract Format

Abstracts must be written in English.
Maximum length: 300 words, unless the official submission system states otherwise.
The word count applies to the abstract body unless otherwise specified by the organizing committee.
The abstract should be clear, concise, scientifically accurate, and free of unexplained abbreviations.
The title, author list, affiliations, and abstract body should be checked carefully before submission.

7. Title Requirements

The title should be brief, specific, and informative.
Avoid vague titles such as “A Rare Case” or “Our Experience.”
Avoid unnecessary abbreviations.
The title should clearly reflect the main topic, population, method, or finding when possible.

8. Author List and Affiliations

Include all authors who made a meaningful contribution to the work.
Author order must be approved by all co-authors before submission.
The first author should usually be the main contributor.
The corresponding author must provide accurate contact information.
The last author may be the supervisor, senior author, or principal investigator when appropriate; however, authorship order must reflect actual contribution.
List the institution, department, city, and country for each author. Use consistent formatting for all affiliations.

9. Abstract Structure for Original Research Studies

Section	What to include
Background	Briefly introduce the problem, knowledge gap, clinical relevance, or scientific rationale.
Objective	State the aim, hypothesis, or research question clearly.
Methods	Describe the study design, setting, participants or materials, intervention or exposure when relevant, main outcomes, and statistical approach.
Results	Present the main findings using specific data whenever available. Include effect sizes, percentages, confidence intervals, or p-values where appropriate.
Conclusion	State the main interpretation, implication, or relevance of the findings. Do not overstate the results.

Minimum standard for research abstracts

A strong research abstract must show what was studied, how it was studied, what was found, and why the findings matter.

10. Abstract Structure for Clinical Case Reports or Case Series

Section	What to include
Background	Explain why the case is important, rare, unusual, clinically relevant, or educational.
Case Presentation	Summarize the patient presentation, key findings, diagnostic work-up, management, and outcome. Do not include identifiable patient information.
Discussion	Explain the diagnostic challenge, therapeutic lesson, clinical reasoning, or broader relevance of the case.
Conclusion	State the key take-home message for clinicians or researchers.

When a clinical case is suitable

A clinical case is suitable when it teaches something beyond routine practice. Good cases usually involve rarity, unexpected diagnosis, management dilemma, unusual complication, or an important safety/ethical lesson.

A common case with no clear lesson is usually not competitive.

11. Scientific and Ethical Requirements

All submitted work must be scientifically accurate and ethically conducted.
For studies involving patients, human data, or biological samples, ethics approval or institutional permission should be obtained when required.
Clinical cases must protect patient confidentiality. Identifying patient details must not be included.
Informed consent should be obtained for case reports when required by institutional or conference policy.
Conflicts of interest, funding sources, and relevant financial relationships should be declared.
Previously published or previously presented work should be disclosed according to the conference rules.
AI-assisted writing, editing, or analysis should be used responsibly and disclosed if required by the conference policy.

12. Submission Information to Provide

Field	Required information
Presentation type	Preferred format: oral or poster.
Congress section/subsection	Select the most relevant scientific or clinical area.
Abstract type	Research study, clinical case, public health, medical education, quality improvement, or other.
YIA eligibility	Yes or no; confirm first author age if applying.
Presenting author	Name, affiliation, and contact details.
Corresponding author	Name, email address, and institution.
Authors and affiliations	Complete author list with consistent institutional information.
Ethics/consent	Ethics approval, institutional permission, or consent statement when relevant.
Funding/COI	Funding sources and conflicts of interest, if applicable.

13. Language of Abstract and Presentation

Abstracts must be submitted in English. Presentation language options: Armenian, English, or Russian.

14. Review Criteria

Abstracts may be reviewed using the following criteria:

Relevance to the conference scope.
Scientific or clinical importance.
Originality or educational value.
Clarity of objective or clinical lesson.
Appropriateness of methods or case description.
Strength and specificity of results.
Ethical compliance and patient confidentiality.
Quality of writing and structure.
Potential impact for practice, research, education, or health-system improvement.

15. Final Checklist Before Submission

Check	Requirement
	The abstract is written in English.
	The abstract does not exceed 300 words, unless otherwise specified.
	The title is clear, specific, and informative.
	The correct congress section and subsection are selected.
	The correct abstract type is selected.
	YIA eligibility is correctly indicated.
	The presenting author is clearly identified.
	All authors and affiliations are accurate.
	All co-authors have approved the submission.
	The abstract follows the correct structure for research or clinical case submissions.
	For research abstracts, methods and results are included.
	For case reports, the clinical lesson is clearly stated.
	Patient confidentiality is protected.
	Ethics approval, institutional permission, or consent is addressed when relevant.
	Conflicts of interest and funding are declared when relevant.
	The text has been proofread for grammar, spelling, and unexplained abbreviations.
	No unsupported conclusions or exaggerated claims are included.
	The abstract is ready for submission according to the official conference rules.

Accepted Abstracts

A rare jejunal gastrointestinal stromal tumor as a cause of widespread peritonitis

Narek Dallakyan, Andranik Khachatryan, Vardan Borozan, Koryun Dallakyan

Anesthetic features during living donor liver transplantation

Artur Hovhannisyan, Hayk Antonyan, Anahit Hakheyan, Tigran Davoyan, Artavazd Ghambaryan, Sona Sargsyan, Hayk Harutyunyan

Assessment of arrhythmogenic risk in patients with arrhythmogenic mitral valve prolaps after surgical mitral valve repair

Karen Harutyunyan, Thomas Fink